1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minne-sota. Gastroenterology. 1997; 112:1448–1456.
Article
2. Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004; 19(suppl 3):S22–S25.
Article
3. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008; 27:173–185.
Article
4. Okamoto K, Iwakiri R, Mori M, et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci. 2003; 48:2237–2241.
Article
5. Wai CT, Yeoh KG, Ho KY, Kang JY, Lim SG. Diagnostic yield of upper endoscopy in Asian patients presenting with dyspepsia. Gastrointest Endosc. 2002; 56:548–551.
Article
6. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci. 2004; 49:237–242.
Article
7. Gerson LB, Edson R, Lavori PW, Triadafilopoulos G. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol. 2001; 96:2005–2012.
Article
8. El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut. 2007; 56:749–755.
Article
9. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007; 133:34–41.
Article
10. Gerson LB, Ullah N, Fass R, Green C, Shetler K, Singh G. Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease? Aliment Pharmacol Ther. 2007; 25:1079–1086.
Article
11. Lagergren J, Bergstrom R, Nyré n O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000; 47:26–29.
Article
12. El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005; 100:2151–2156.
Article
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372:425–432.
Article
14. Ogunwobi O, Mutungi G, Beales IL. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prosta-glandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006; 147:4505–4516.
Article
15. Somasundar P, Riggs D, Jackson B, Vona-Davis L, McFadden DW. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg. 2003; 186:575–578.
Article
16. Francois F, Roper J, Goodman AJ, et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut. 2008; 57:16–24.
Article
17. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363:157–163.
18. DiBaise JK. The LA classification for esophagitis: a call for standardization. Am J Gastroenterol. 1999; 94:3403–3404.
Article
19. DeVault KR, Castell DO; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005; 100:190–200.
20. Pace F, Bianchi Porro G. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am J Gastroenterol. 2004; 99:946–949.
Article
21. Fass R, Ofman JJ. Gastroesophageal reflux disease–should we adopt a new conceptual framework? Am J Gastroenterol. 2002; 97:1901–1909.
Article
22. Aparicio T, Kermorgant S, Darmoul D, et al. Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J Clin Endocrinol Metab. 2005; 90:6177–6184.
Article
23. Considine RV, Sinha MK, Heiman ML, et al. Serum im-munoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996; 334:292–295.
Article
24. Azuma T, Suto H, Ito Y, et al. Gastric leptin and Helicobacter pylori infection. Gut. 2001; 49:324–329.
Article
25. Kendall BJ, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus. Gut. 2008; 57:448–454.
Article
26. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007; 56:756–762.
Article
27. Kang MS, Park DI, Oh SY, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007; 22:1656–1661.
Article
28. Lee HL, Eun CS, Lee OY, et al. Association between GERD- related erosive esophagitis and obesity. J Clin Gastroenterol. 2008; 42:672–675.